- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma in Australia
Total 647 results
-
IGM Biosciences, Inc.ADC Therapeutics S.A.Active, not recruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | DLBCLUnited States, Korea, Republic of, Spain, France, Australia, Czechia, Italy
-
Mundipharma Research LimitedTerminatedIndolent B-cell NHLAustralia, Slovakia
-
Nordic NanovectorICON Clinical ResearchActive, not recruitingFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Medical University of ViennaRoche Pharma AG; Allcyte GmbHRecruitingRefractory Acute Myeloid Leukemia | Advanced Lymphoma | Refractory Lymphoma | Refractory Leukemia | Refractory T-Cell LymphomaAustria
-
Novartis PharmaceuticalsXOMA (US) LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States, Belgium, Canada, Italy, France, Hong Kong, Australia, United Kingdom, Singapore, Korea, Republic of, Germany
-
Hoffmann-La RocheCompletedB-cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Austria, Poland
-
Dizal PharmaceuticalsNot yet recruitingLymphoma, Non-HodgkinAustralia
-
CephalonCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaAustralia, Canada, United States
-
Dren BioNovotech (Australia) Pty LimitedRecruitingB-cell Non Hodgkin LymphomaAustralia, Hong Kong, Korea, Republic of, Singapore, Taiwan
-
PfizerCompletedNon-Hodgkin's LymphomaKorea, Republic of, Australia, Czechia, United States, Romania, Germany, France, Poland, Italy, Russian Federation, Serbia
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
Genentech, Inc.RecruitingSolid Tumor, Adult | Refractory Cancer | Recurrent CancerAustralia
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Italy, Austria, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
-
Eisai Inc.Dr. Reddy's Laboratory; Citius PharmaceuticalsCompletedPersistent or Recurrent Cutaneous T-Cell LymphomaUnited States, Australia, Puerto Rico
-
AmgenCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy, United Kingdom, Germany, France
-
Epizyme, Inc.RecruitingFollicular Lymphoma | Relapsed/Refractory Follicular Lymphoma | Refractory Follicular LymphomaUnited States, China, Spain, France, Taiwan, United Kingdom, Australia, Korea, Republic of, Canada, Italy, Hungary, Poland, Belgium, Germany
-
Gilead SciencesThe Leukemia and Lymphoma SocietyTerminatedNon Hodgkin LymphomaUnited States, Australia, United Kingdom
-
Genentech, Inc.CompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaBelgium, Australia, Denmark, Norway
-
GenmabRecruitingNon-Hodgkin Lymphoma | Classical Hodgkin LymphomaUnited States, Australia
-
Regeneron PharmaceuticalsCompletedRelapsed/Refractory Follicular LymphomaAustria, France, Germany, United Kingdom
-
Hoffmann-La RocheRecruitingMature B-Cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Denmark, Australia, Germany, Italy
-
Swiss Group for Clinical Cancer ResearchCompletedLymphomaItaly, Switzerland, Austria, Germany, Greece
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Hoffmann-La RocheTerminatedNon-Hodgkin's LymphomaUnited States, Australia, Korea, Republic of, Germany, New Zealand
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory Large B-cell LymphomaUnited States, Australia, Canada
-
Peter MacCallum Cancer Centre, AustraliaCompletedHodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralAustralia
-
Gilead SciencesUnknownLymphomaSwitzerland, United States, Italy, Sweden, Austria
-
Gilead SciencesUnknownLymphomaSwitzerland, United States, Italy, Sweden, Austria
-
CephalonCompletedNon-Hodgkin's LymphomaUnited States, Australia, Canada
-
NCIC Clinical Trials GroupCompletedLymphomaUnited States, Canada, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingOsteosarcoma | Lymphoblastic Lymphoma | Recurrent Lymphoma | Recurrent Malignant Neoplasm | Hodgkin Lymphoma in Remission | Leukemia in Remission | Recurrent LeukemiaUnited States, Australia, Canada, Puerto Rico
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy
-
Innate PharmaRecruitingNon Hodgkin LymphomaFrance, United States, Australia
-
PfizerUCB PharmaCompletedB-Cell LymphomaUnited States, Belgium, Korea, Republic of, Switzerland, France, Poland, Spain, Hong Kong, Australia, Germany, Italy, Netherlands, United Kingdom
-
BiogenCompletedNon-Hodgkin's LymphomaSweden, Czech Republic, France, Russian Federation, Turkey, United Kingdom, Germany, Lithuania, Romania, United States, Austria
-
Therapeutic Advances in Childhood Leukemia ConsortiumPfizerCompletedLymphoblastic Lymphoma | Peripheral T-cell Lymphoma | Lymphoblastic Leukemia, Acute, ChildhoodUnited States, Canada, Australia
-
MEI Pharma, Inc.Kyowa Kirin, Inc.TerminatedPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Taiwan, Australia, Poland, Italy, Canada, Georgia, Greece, Hungary, Netherlands, New Zealand, Serbia, Turkey
-
Hoffmann-La RocheInstitute of Cancer Research, United Kingdom; German Low Grade Lymphoma Study...CompletedNon-Hodgkin's LymphomaItaly, Belgium, Canada, United Kingdom, Australia, China, Germany, United States, Russian Federation, Spain, Taiwan, Israel, Czechia, Hungary, Japan, France, Finland, Sweden
-
Gilead SciencesTerminated
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaItaly, United Kingdom, Belgium, Brazil, Denmark, France, Peru, Colombia, Canada, Georgia, Singapore, Spain, Thailand, Australia, Germany, Mexico, Russian Federation, South Africa, Finland, Bosnia and Herzegovina, Bulgaria, Croatia, ... and more
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaBelgium, Italy, Spain, United States, Canada, Sweden, Greece, Netherlands, Austria, Switzerland, Poland, Turkey, Croatia, Brazil, Argentina, Denmark, United Kingdom
-
AbbVieRecruitingDiffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | B Cell MalignanciesUnited States, Israel, Australia, France, United Kingdom, Belgium, Spain
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaItaly, Brazil, Slovenia, Spain, Germany, Switzerland, Russian Federation, Israel, Sweden, Albania, Argentina, Australia, Bosnia and Herzegovina, Bulgaria, Colombia, Croatia, Ecuador, Egypt, Finland, Greece, Mexico, Romania, Slovakia, ...
-
European Organisation for Research and Treatment...NCIC Clinical Trials Group; Stichting Hemato-Oncologie voor Volwassenen Nederland and other collaboratorsCompletedLymphomaFrance, Netherlands, United Kingdom, Australia, Canada, Norway, Poland, Belgium, Italy, New Zealand, Denmark, Egypt, Hungary, Portugal, Slovakia, Slovenia, South Africa, Sweden
-
National Cancer Institute (NCI)CompletedRecurrent Adult Lymphoblastic Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | B-cell Adult Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States, Australia, Brazil, Canada, Mexico, New Zealand, Peru
-
CelgeneCelgene CorporationCompletedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States, Australia
-
Sana BiotechnologyRecruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States, Australia
-
Genentech, Inc.Roche Pharma AGCompletedNon-Hodgkin's LymphomaUnited States, Spain, France, Canada, United Kingdom, Austria, Belgium, Czechia, Russian Federation, Italy, Switzerland, Germany, Netherlands, Sweden